🔴 Neurosense Therapeutics is trading 5.7% down in after-hours trading as all three major U.S. indexes fell

Neurosense Therapeutics is trading 5.7% lower at $4.80 in after-hours trading amid broader market weakness.

• It closed September 28 at $5.09. Reuters reported declines in all three major U.S. indexes as investors weighed renewed U.S.-Iran tensions, elevated oil prices and Treasury yields.
• No company-specific announcement explaining the drop was identified for September 28. The company announced CFO participation in a September 29 investor conference, but available reporting does not establish it as the cause.